On the public citation graph
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
0 signed · 964 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/s0140-6736(11)60136-0openalex-snapshot
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
inferredcites →https://doi.org/10.1016/s1473-3099(11)70024-xopenalex-snapshot
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
inferredcites →https://doi.org/10.1016/s1473-3099(11)70344-9openalex-snapshot
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
inferredcites →https://doi.org/10.1038/clpt.2009.140openalex-snapshot
The Forum for Collaborative HIV Research: A Model for an Integrated and Inclusive Approach to Clinical Research and Drug Development
inferredcites →https://doi.org/10.1038/clpt.2014.113openalex-snapshot
Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group
inferredcites →https://doi.org/10.1056/nejm199104113241501openalex-snapshot
A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants
inferredcites →https://doi.org/10.1056/nejmoa1303688openalex-snapshot
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
inferredcites →https://doi.org/10.1056/nejmoa1309533openalex-snapshot
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
inferredcites →https://doi.org/10.1086/339329openalex-snapshot
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
inferredcites →https://doi.org/10.1093/cid/ciw370openalex-snapshot
Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples
inferredcites →https://doi.org/10.1111/j.1600-6143.2010.03074.xopenalex-snapshot
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients
inferredcites →https://doi.org/10.1128/jcm.01495-15openalex-snapshot
Commutability of the First World Health Organization International Standard for Human Cytomegalovirus
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3904656openalex-extracted
Comparison of Transplant Donor- and Third-Party Donor-Derived CMV-Specific T Cells for CMV Infection After Allogenic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1001/jama.2023.9106openalex-snapshot
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1001/jama.2025.14338openalex-snapshot
Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children
inferred← citeshttps://doi.org/10.1002/9781119633884.ch92openalex-snapshot
Transplant Infectious Diseases
inferred← citeshttps://doi.org/10.1002/aid2.13429openalex-snapshot
The role of immunohistochemistry staining and hematoxylin & eosin staining in the diagnosis of cytomegalovirus disease of the gastrointestinal tract
inferred← citeshttps://doi.org/10.1002/ajh.25585openalex-snapshot
A bronchoalveolar lavage‐driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group
inferred← citeshttps://doi.org/10.1002/ajh.26535openalex-snapshot
Adoptive therapy with cytomegalovirus ‐specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy
inferred← citeshttps://doi.org/10.1002/ccr3.8435openalex-snapshot
Cytomegalovirus colitis in immunocompetent hosts: A case report and literature review
inferred← citeshttps://doi.org/10.1002/cpt.70155openalex-snapshot
Letermovir Prophylaxis for CMV DNAemia /Disease after HLA ‐Mismatched HSCT : A Retrospective Real‐World Analysis with Overlap Propensity Score Weighting
inferred← citeshttps://doi.org/10.1002/dc.25384openalex-snapshot
The need for “eagle‐eyed screening”: Owl's eyes in bronchoalveolar lavage cytology
inferred← citeshttps://doi.org/10.1002/ehf2.13835openalex-snapshot
Sarcopenia and Risk of Infection in Adult Heart Transplant Recipients in Japan
inferred← citeshttps://doi.org/10.1002/eji.202249940openalex-snapshot
Acute cytomegalovirus infection modulates the intestinal microbiota and targets intestinal epithelial cells
inferred← citeshttps://doi.org/10.1002/hon.2453openalex-snapshot
Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant
inferred← citeshttps://doi.org/10.1002/iid3.1075openalex-snapshot
Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation
inferred← citeshttps://doi.org/10.1002/iid3.371openalex-snapshot
Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipients
inferred← citeshttps://doi.org/10.1002/iid3.431openalex-snapshot
Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
inferred← citeshttps://doi.org/10.1002/iid3.508openalex-snapshot
Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
inferred← citeshttps://doi.org/10.1002/jac5.2061openalex-snapshot
Impact of an intern‐supported antiviral stewardship program for cytomegalovirus prophylaxis and management in high‐risk abdominal solid organ transplant recipients
inferred← citeshttps://doi.org/10.1002/jcp.30335openalex-snapshot
HCMV modulates c‐Mpl/IEX‐1 pathway‐mediated megakaryo/thrombopoiesis via PDGFRα and αvβ3 receptors after allo‐HSCT
inferred← citeshttps://doi.org/10.1002/jcph.1363openalex-snapshot
Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives
inferred← citeshttps://doi.org/10.1002/jha2.183openalex-snapshot
Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
inferred← citeshttps://doi.org/10.1002/jlb.4mr1221-452ropenalex-snapshot
Molecular and immune interactions between β- and γ-herpesviruses in the immunocompromised host
inferred← citeshttps://doi.org/10.1002/jmv.25574openalex-snapshot
Clinical and economic burden of pre‐emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients
inferred← citeshttps://doi.org/10.1002/jmv.25895openalex-snapshot
Clinical and economic impact of treated CMV infection in adult CMV‐seropositive patients after allogeneic hematopoietic cell transplantation
inferred← citeshttps://doi.org/10.1002/jmv.26462openalex-snapshot
Cost‐effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective
inferred← citeshttps://doi.org/10.1002/jmv.26649openalex-snapshot
Comparing cytomegalovirus diagnostics by cell culture and quantitative nucleic acid testing in broncho‐alveolar lavage fluids
inferred← citeshttps://doi.org/10.1002/jmv.27421openalex-snapshot
Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID‐19
inferred← citeshttps://doi.org/10.1002/jmv.28507openalex-snapshot
ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients
inferred← citeshttps://doi.org/10.1002/jmv.28733openalex-snapshot
Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients
inferred← citeshttps://doi.org/10.1002/jmv.29139openalex-snapshot
Amplicon size and non‐encapsidated DNA fragments define plasma cytomegalovirus DNA loads by automated nucleic acid testing platforms: A marker of viral cytopathology?
inferred← citeshttps://doi.org/10.1002/jmv.70128openalex-snapshot
Cytomegalovirus Disease in Renal Allograft Recipients in the Current Immunosuppression Era
inferred← citeshttps://doi.org/10.1002/jmv.70178openalex-snapshot
Human Cytomegalovirus Infection Induces Long‐Term Changes in the Cytokine Milieu of Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1002/jmv.70489openalex-snapshot
Epstein–Barr Virus Infection and CD4+CD28+ T Cells Immune Construction Status Were Associated With the Incidence of Cytomegalovirus Encephalitis in Patients After Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1002/jmv.71053openalex-snapshot
Surveillance of CMV Terminase Gene Mutations in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir Prophylaxis
inferred← citeshttps://doi.org/10.1002/jmv.71163openalex-snapshot
Cytomegalovirus in Bronchoalveolar Lavage Fluid: A Predictor of Outcome in Immunocompromised Patients
inferred← citeshttps://doi.org/10.1002/lt.25047openalex-snapshot
Low‐dose valganciclovir for cytomegalovirus prophylaxis in intermediate‐risk liver transplantation recipients
inferred← citeshttps://doi.org/10.1002/pbc.28101openalex-snapshot
Cytomegalovirus disease in a retinoblastoma cohort: The role of preemptive screening
inferred← citeshttps://doi.org/10.1002/pbc.28673openalex-snapshot
Systemic viral infection in children receiving chemotherapy for acute leukemia
inferred← citeshttps://doi.org/10.1002/pbc.29174openalex-snapshot
Parental limited English proficiency in pediatric stem cell transplantation: Clinical impact and health care utilization
inferred← citeshttps://doi.org/10.1002/pbc.31732openalex-snapshot
Comparison of Letermovir Versus Ganciclovir for Cytomegalovirus Prophylaxis in Pediatric Hematopoietic Stem Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1002/phar.2714openalex-snapshot
Early versus delayed initiation of cytomegalovirus prophylaxis after liver transplant
inferred← citeshttps://doi.org/10.1002/rmv.1958openalex-snapshot
Criteria to define interruption of transmission of human cytomegalovirus from organ donor to recipient
inferred← citeshttps://doi.org/10.1002/rmv.70120openalex-snapshot
CMV Preventive and Treatment Studies in Children Undergoing Haematopoietic Stem Cell Transplant: A Systematic Review
inferred← citeshttps://doi.org/10.1002/sctm.20-0099openalex-snapshot
Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study
inferred← citeshttps://doi.org/10.1007/7854_2022_376openalex-snapshot
Effect of Cytomegalovirus on the Immune System: Implications for Aging and Mental Health
inferred← citeshttps://doi.org/10.1007/978-1-0716-1987-2_8openalex-snapshot
Management of Hospitalized Patients with Inflammatory Bowel Disease and CMV Infection or Clostridium Difficile Infection
inferred← citeshttps://doi.org/10.1007/978-3-030-01751-4_24-1openalex-snapshot
Cytomegalovirus in Solid Organ Transplant Recipients: Prevention, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-01751-4_25-1openalex-snapshot
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients: Prevention, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-25869-6_24openalex-snapshot
Cytomegalovirus in Solid Organ Transplant Recipients: Prevention, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-030-25869-6_25openalex-snapshot
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients: Prevention, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.1007/978-3-031-28797-8_10openalex-snapshot
Cytomegalovirus Diseases in Hematopoietic Cell Transplant Recipients
inferred← citeshttps://doi.org/10.1007/978-3-031-57369-9_15openalex-snapshot
Cytomegalovirus Infections in Hematopoietic Cell Transplant and Solid Organ Transplant Recipients
inferred← citeshttps://doi.org/10.1007/978-3-031-97506-6_15openalex-snapshot
Transplant Liver Pathology
inferred← citeshttps://doi.org/10.1007/978-3-031-98076-3_15openalex-snapshot
Care of the Pediatric Solid Organ Transplant Recipient
inferred← citeshttps://doi.org/10.1007/978-3-032-12629-0_4openalex-snapshot
Infections After Cardiac Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-319-07284-5_71openalex-snapshot
Posttransplant Complications and Comorbidities
inferred← citeshttps://doi.org/10.1007/978-3-319-08049-9_71-1openalex-snapshot
Post-Transplant Complications and Comorbidities
inferred← citeshttps://doi.org/10.1007/978-3-319-97873-4_38openalex-snapshot
Infections in Hematology Patients
inferred← citeshttps://doi.org/10.1007/978-3-662-46764-0_155-1openalex-snapshot
Therapie von Infektionen bei Tumorpatienten
inferred← citeshttps://doi.org/10.1007/s00134-019-05906-5openalex-snapshot
Diagnosis of severe respiratory infections in immunocompromised patients
inferred← citeshttps://doi.org/10.1007/s00134-023-07295-2openalex-snapshot
ICU-acquired infections in immunocompromised patients
inferred← citeshttps://doi.org/10.1007/s00134-024-07737-5openalex-snapshot
What intensivists need to know about cytomegalovirus infection in immunocompromised ICU patients
inferred← citeshttps://doi.org/10.1007/s00203-023-03623-8openalex-snapshot
Immune-checkpoint expression in antigen-presenting cells (APCs) of cytomegaloviruses infection after transplantation: as a diagnostic biomarker
inferred← citeshttps://doi.org/10.1007/s00277-018-3585-1openalex-snapshot
Cytomegalovirus infection is associated with AML relapse after allo-HSCT: a meta-analysis of observational studies
inferred← citeshttps://doi.org/10.1007/s00277-020-04156-6openalex-snapshot
Risk factors and associations with clinical outcomes of cytomegalovirus reactivation after haploidentical versus matched-sibling unmanipulated PBSCT in patients with hematologic malignancies
inferred← citeshttps://doi.org/10.1007/s00277-020-04201-4openalex-snapshot
Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1007/s00277-021-04622-9openalex-snapshot
Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa
inferred← citeshttps://doi.org/10.1007/s00277-021-04707-5openalex-snapshot
Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants
inferred← citeshttps://doi.org/10.1007/s00277-021-04730-6openalex-snapshot
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area
inferred← citeshttps://doi.org/10.1007/s00277-022-04841-8openalex-snapshot
Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms
inferred← citeshttps://doi.org/10.1007/s00277-023-05332-0openalex-snapshot
Time-dependent analysis of the impact on early cytomegalovirus reactivation of HLA mismatch and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation from related donors in acquired aplastic anemia
inferred← citeshttps://doi.org/10.1007/s00277-024-05791-zopenalex-snapshot
Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia
inferred← citeshttps://doi.org/10.1007/s00277-024-05839-0openalex-snapshot
Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine
inferred← citeshttps://doi.org/10.1007/s00277-025-06684-5openalex-snapshot
Mesenchymal stem cells for the adjunctive treatment of cytomegalovirus pneumonia in hematopoietic stem cell transplant recipients: a Single-center prospective study
inferred← citeshttps://doi.org/10.1007/s00296-022-05196-zopenalex-snapshot
Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease
inferred← citeshttps://doi.org/10.1007/s00408-020-00403-9openalex-snapshot
Infectious Complications in Lung Transplant Recipients
inferred← citeshttps://doi.org/10.1007/s00430-021-00722-5openalex-snapshot
Human cytomegalovirus multiple-strain infections and viral population diversity in haematopoietic stem cell transplant recipients analysed by high-throughput sequencing
inferred← citeshttps://doi.org/10.1007/s00431-022-04614-5openalex-snapshot
Impact of cytomegalovirus infection prior to hematopoietic stem cell transplantation in children with inborn errors of immunity
inferred← citeshttps://doi.org/10.1007/s00520-023-08258-5openalex-snapshot
Risk factors and clinical outcomes of cytomegalovirus diseases in hematologic malignancy patients without hematopoietic stem-cell transplantation
inferred← citeshttps://doi.org/10.1007/s10067-025-07456-2openalex-snapshot
The clinical and immunological features of CMV infection in rheumatic patients: a nested case-control study
inferred← citeshttps://doi.org/10.1007/s10096-018-3387-3openalex-snapshot
Real-time quantitative PCR analysis of endoscopic biopsies for diagnosing CMV gastrointestinal disease in non-HIV immunocompromised patients: a diagnostic accuracy study
inferred← citeshttps://doi.org/10.1007/s10096-018-3405-5openalex-snapshot
Single-center analysis of infectious complications in older adults during the first year after kidney transplantation
inferred← citeshttps://doi.org/10.1007/s10096-019-03744-3openalex-snapshot
Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus–positive kidney transplant recipient
inferred← citeshttps://doi.org/10.1007/s10096-020-03990-wopenalex-snapshot
Letermovir for the compassionate therapeutic use of cytomegalovirus infection
inferred← citeshttps://doi.org/10.1007/s10096-024-04977-7openalex-snapshot
Role of letermovir therapeutic drug monitoring for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplantation recipients: a prospective study
inferred← citeshttps://doi.org/10.1007/s10157-021-02117-5openalex-snapshot
Risk factors for cytomegalovirus reactivation in patients with kidney disease under immunosuppressive therapy
inferred← citeshttps://doi.org/10.1007/s10157-024-02471-0openalex-snapshot
Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study
inferred← citeshttps://doi.org/10.1007/s10157-024-02578-4openalex-snapshot
Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective study
inferred← citeshttps://doi.org/10.1007/s10238-023-01270-3openalex-snapshot
Early T-cell reconstitution predicts risk of EBV reactivation after allogeneic hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1007/s10405-019-0251-9openalex-snapshot
Die Cytomegalievirus-Pneumonie
inferred← citeshttps://doi.org/10.1007/s10875-020-00873-9openalex-snapshot
Cytomegalovirus Laryngitis in Primary Combined Immunodeficiency Diseases
inferred← citeshttps://doi.org/10.1007/s10875-023-01617-1openalex-snapshot
Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity
inferred← citeshttps://doi.org/10.1007/s11255-020-02676-8openalex-snapshot
Cytomegalovirus disease in de novo kidney-transplant recipients: comparison of everolimus-based immunosuppression without prophylaxis with mycophenolic acid-based immunosuppression with prophylaxis
inferred← citeshttps://doi.org/10.1007/s11255-021-02973-wopenalex-snapshot
Cytomegalovirus infection in patients with glomerular diseases treated with cyclophosphamide: a single-center prospective study
inferred← citeshttps://doi.org/10.1007/s11684-020-0807-4openalex-snapshot
Outcomes of haploidentical bone marrow transplantation in patients with severe aplastic anemia-II that progressed from non-severe acquired aplastic anemia
inferred← citeshttps://doi.org/10.1007/s11908-019-0681-xopenalex-snapshot
Challenges and Clinical Implications of the Diagnosis of Cytomegalovirus Lung Infection in Children
inferred← citeshttps://doi.org/10.1007/s12088-024-01333-3openalex-snapshot
The Characteristics and Risk Factors of Cytomegalovirus Infection in Dermatomyositis
inferred← citeshttps://doi.org/10.1007/s12185-018-2544-xopenalex-snapshot
Cytomegalovirus meningitis in a patient with relapsed acute myeloid leukemia
inferred← citeshttps://doi.org/10.1007/s12185-025-04023-yopenalex-snapshot
Cytomegalovirus reactivation in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
inferred← citeshttps://doi.org/10.1007/s12185-026-04220-3openalex-snapshot
Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study
inferred← citeshttps://doi.org/10.1007/s12288-018-0960-yopenalex-snapshot
A Low Incidence of Cytomegalo Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplantation Despite a High Seroprevalence
inferred← citeshttps://doi.org/10.1007/s12288-023-01655-0openalex-snapshot
CMV Infection Post Allogeneic Hematopoietic Stem Cell Transplantation in a Resource Limited Country
inferred← citeshttps://doi.org/10.1007/s12325-025-03210-xopenalex-snapshot
Patient Number and Treatment Patterns in Cytomegalovirus Viremia and Disease Following Solid Organ and Hematopoietic Stem Cell Transplantation in Germany: Results of a Delphi Consensus Study
inferred← citeshttps://doi.org/10.1007/s13665-020-00246-yopenalex-snapshot
Human Cytomegalovirus Prophylaxis and Treatment in Lung Transplantation in the Current Era
inferred← citeshttps://doi.org/10.1007/s13691-025-00822-6openalex-snapshot
Acute esophageal mucosal injury during pembrolizumab treatment after a hypopharyngeal cancer patient’s free jejunal autograft reconstruction, as an immune-related adverse event
inferred← citeshttps://doi.org/10.1007/s15010-022-01847-2openalex-snapshot
Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data
inferred← citeshttps://doi.org/10.1007/s15010-024-02441-4openalex-snapshot
Prophylactic vs preemptive strategy for the prevention of CMV disease in solid organ transplant recipients: systematic review and meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1007/s15010-025-02499-8openalex-snapshot
The adverse impact of cytomegalovirus infection on intensive care units outcomes in critically ill COVID-19 patients: a single-center prospective observational study
inferred← citeshttps://doi.org/10.1007/s40121-017-0180-zopenalex-snapshot
Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation
inferred← citeshttps://doi.org/10.1007/s40121-021-00528-1openalex-snapshot
A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus
inferred← citeshttps://doi.org/10.1007/s40121-023-00850-wopenalex-snapshot
Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1007/s40121-024-00917-2openalex-snapshot
Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1007/s40506-021-00253-wopenalex-snapshot
CMV Infection in Hematopoietic Stem Cell Transplantation: Prevention and Treatment Strategies
inferred← citeshttps://doi.org/10.1007/s40620-021-01161-4openalex-snapshot
Efficacy and side effect profile of two CMV prophylaxis strategies in high and intermediate risk kidney transplant recipients – a multicentre national study
inferred← citeshttps://doi.org/10.1007/s40620-022-01373-2openalex-snapshot
De-novo CMV infection manifesting as interstitial nephritis in a high-risk kidney recipient with concurrent urologic complications: lessons for the clinical nephrologist
inferred← citeshttps://doi.org/10.1007/s41669-023-00398-yopenalex-snapshot
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States
inferred← citeshttps://doi.org/10.1007/s41669-026-00679-2openalex-snapshot
Budget Impact of Prophylactic Letermovir to Prevent Cytomegalovirus Disease in High-Risk Adult Kidney Transplant Recipients
inferred← citeshttps://doi.org/10.1007/s44231-025-00086-xopenalex-snapshot
Management of Severe Complications after Lung Transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-08-102723-3.00259-6openalex-snapshot
Opportunistic Bacterial, Fungal and Viral Infections in Lung Transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-12-814515-9.00134-xopenalex-snapshot
Treatment and Prevention of Herpesvirus Infections in the Immunocompromised Host
inferred← citeshttps://doi.org/10.1016/b978-0-12-815499-1.00054-5openalex-snapshot
Infectious diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-818619-0.00110-6openalex-snapshot
Viral monitoring in immunocompromised hosts
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00072-8openalex-snapshot
Infections in Pediatric Heart Transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00073-xopenalex-snapshot
Infections in Pediatric Lung Transplantation
inferred← citeshttps://doi.org/10.1016/j.ajt.2023.10.007openalex-snapshot
Risk of cytomegalovirus infection and subsequent allograft failure after pancreas transplantation
inferred← citeshttps://doi.org/10.1016/j.ajt.2024.05.016openalex-snapshot
Invasive aspergillosis in liver transplant recipients in the current era
inferred← citeshttps://doi.org/10.1016/j.ajt.2024.09.025openalex-snapshot
Cytomegalovirus prophylaxis in pediatric liver transplantation: A comparison of strategies across the Society of Pediatric Liver Transplantation (SPLIT) consortium
inferred← citeshttps://doi.org/10.1016/j.ajt.2025.03.030openalex-snapshot
Longitudinal assessment of the effect of invasive fungal infections on transplant success in kidney transplant recipients
inferred← citeshttps://doi.org/10.1016/j.ajt.2025.07.2471openalex-snapshot
Impact of kidney function on 200 days of antiviral prophylaxis for cytomegalovirus disease in cytomegalovirus-seronegative recipients of cytomegalovirus-seropositive donor kidneys: Post hoc analysis of a randomized, phase 3 trial of letermovir vs valganciclovir prophylaxis
inferred← citeshttps://doi.org/10.1016/j.ajt.2026.01.027openalex-snapshot
Frequency of viral monitoring to detect cytomegalovirus infection and prevent disease in solid organ transplant recipients: An international, multicenter cohort study
inferred← citeshttps://doi.org/10.1016/j.ajt.2026.07.012openalex-snapshot
Epstein-Barr virus infection monitoring in kidney transplant recipients (EVITA study)—investigating the clinical significance of EBV-DNAemia and the risk of early-onset PTLD
inferred← citeshttps://doi.org/10.1016/j.alit.2025.03.007openalex-snapshot
Recent advances in the diagnosis and treatment of DIHS/DRESS in 2025
inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.09.003openalex-snapshot
New therapies for human cytomegalovirus infections
inferred← citeshttps://doi.org/10.1016/j.antiviral.2025.106150openalex-snapshot
Targeting the host transcription factor HSF1 prevents human cytomegalovirus replication in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/j.aohep.2025.101899openalex-snapshot
Latin American association for the study of the liver (ALEH) guidance on postoperative care after liver transplantation
inferred← citeshttps://doi.org/10.1016/j.athplu.2022.03.003openalex-snapshot
Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events
inferred← citeshttps://doi.org/10.1016/j.bbmt.2017.06.008openalex-snapshot
Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell–Depleted, CD34+ Selected Hematopoietic Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2017.07.025openalex-snapshot
Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.04.013openalex-snapshot
Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.05.001openalex-snapshot
Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.05.008openalex-snapshot
A Modified Intensive Strategy to Prevent Cytomegalovirus Disease in Seropositive Umbilical Cord Blood Transplantation Recipients
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.05.017openalex-snapshot
Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.10.011openalex-snapshot
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.10.020openalex-snapshot
Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.11.012openalex-snapshot
Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.12.586openalex-snapshot
Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2019.01.012openalex-snapshot
Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2019.07.016openalex-snapshot
Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2019.07.042openalex-snapshot
Impact of High-Frequency HLA Haplotypes on Clinical Cytomegalovirus Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2019.10.014openalex-snapshot
Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies
inferred← citeshttps://doi.org/10.1016/j.bbmt.2019.11.005openalex-snapshot
Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy
inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.01.013openalex-snapshot
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching
inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.01.015openalex-snapshot
Features of Cytomegalovirus DNAemia Blips in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Implications for Optimization of Preemptive Antiviral Therapy Strategies
inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.01.027openalex-snapshot
Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program
inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.03.019openalex-snapshot
Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study
inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.06.006openalex-snapshot
Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.06.025openalex-snapshot
Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.bbmt.2020.07.002openalex-snapshot
Letermovir Prophylaxis Decreases Burden of Cytomegalovirus (CMV) in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant
inferred← citeshttps://doi.org/10.1016/j.blre.2022.100944openalex-snapshot
Recent advances in neutropenic enterocolitis: Insights into the role of gut microbiota
inferred← citeshttps://doi.org/10.1016/j.bspc.2020.102163openalex-snapshot
Nonlinear adaptive control of immune response of renal transplant recipients in the presence of uncertainties
inferred← citeshttps://doi.org/10.1016/j.bulcan.2017.10.022openalex-snapshot
Conduite à tenir devant une réactivation EBV et un syndrome lymphoprolifératif à EBV, une réactivation ou infection à CMV et à HHV-6 après allogreffe de cellules souches hématopoïétiques : recommandations de la SFGM-TC (mises à jour)
inferred← citeshttps://doi.org/10.1016/j.bulcan.2019.09.002openalex-snapshot
Prophylaxie antivirale pour le CMV, l’HSV/VZV et le VHB après allogreffe de cellules souches hématopoïétiques chez l’adulte : recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC)
inferred← citeshttps://doi.org/10.1016/j.ccm.2017.07.012openalex-snapshot
Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.ccm.2022.10.012openalex-snapshot
Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial
inferred← citeshttps://doi.org/10.1016/j.chest.2020.05.598openalex-snapshot
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults
inferred← citeshttps://doi.org/10.1016/j.clim.2020.108456openalex-snapshot
Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21
inferred← citeshttps://doi.org/10.1016/j.clim.2021.108792openalex-snapshot
Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation
inferred← citeshttps://doi.org/10.1016/j.clinmicnews.2021.08.003openalex-snapshot
Diagnosis and Monitoring of Viral Infections in the Transplant Population
inferred← citeshttps://doi.org/10.1016/j.clml.2018.10.002openalex-snapshot
Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment
inferred← citeshttps://doi.org/10.1016/j.clml.2026.09.003openalex-snapshot
Infection Prevention and Management in Patients With Multiple Myeloma Treated With Bispecific Antibodies: A Case-Based Approach for Routine Clinical Practice
inferred← citeshttps://doi.org/10.1016/j.cmi.2019.07.024openalex-snapshot
Reporting infectious complications in haematology clinical trials should be improved
inferred← citeshttps://doi.org/10.1016/j.cmi.2021.09.013openalex-snapshot
Human cytomegalovirus non-primary infection during pregnancy: antibody response, risk factors and newborn outcome
inferred← citeshttps://doi.org/10.1016/j.cmi.2021.10.008openalex-snapshot
The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.cmi.2022.05.034openalex-snapshot
Comparative clinical manifestations and immune effects of cytomegalovirus infections following distinct types of immunosuppression
inferred← citeshttps://doi.org/10.1016/j.cmi.2023.10.008openalex-snapshot
Trimethoprim-sulfamethoxazole significantly reduces the risk of nocardiosis in solid organ transplant recipients: systematic review and individual patient data meta-analysis
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2025.116926openalex-snapshot
CMV retinitis in HIV-infected patients: Plasma viral load utility in diagnosis
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2025.116967openalex-snapshot
Cytomegalovirus reactivation among immunocompetent patients hospitalized in medical intensive care: Associated factors and consequences
inferred← citeshttps://doi.org/10.1016/j.eclinm.2025.103300openalex-snapshot
Advocating for the recognition of underlying immunosuppression in critical illness
inferred← citeshttps://doi.org/10.1016/j.eclinm.2025.103371openalex-snapshot
Management of Clostridioides difficile infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10)
inferred← citeshttps://doi.org/10.1016/j.eclinm.2026.103792openalex-snapshot
Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case–control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT
inferred← citeshttps://doi.org/10.1016/j.eimc.2020.01.021openalex-snapshot
Prevention and therapy of viral infections in patients with solid organ transplantation
inferred← citeshttps://doi.org/10.1016/j.eimce.2020.01.019openalex-snapshot
Prevention and therapy of viral infections in patients with solid organ transplantation
inferred← citeshttps://doi.org/10.1016/j.ejca.2025.116103openalex-snapshot
CNS infections in patients with hematological or oncological diseases (including cellular therapies) – 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
inferred← citeshttps://doi.org/10.1016/j.ejcped.2023.100131openalex-snapshot
Virus infections after allogeneic stem cell transplantation in children. Review
inferred← citeshttps://doi.org/10.1016/j.emc.2019.07.008openalex-snapshot
Evaluation of the Renal Transplant Recipient in the Emergency Department
inferred← citeshttps://doi.org/10.1016/j.exphem.2025.104859openalex-snapshot
Impaired CMV-specific CD4+ T-cell reconstitution is associated with CMV infection after letermovir cessation
inferred← citeshttps://doi.org/10.1016/j.gtc.2021.02.013openalex-snapshot
Infectious Gastroenteritis in Transplant Patients
inferred← citeshttps://doi.org/10.1016/j.healun.2021.12.005openalex-snapshot
Cytomegalovirus prevention in thoracic organ transplantation: A single-center evaluation of letermovir prophylaxis
inferred← citeshttps://doi.org/10.1016/j.healun.2025.09.017openalex-snapshot
Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement
inferred← citeshttps://doi.org/10.1016/j.hemonc.2017.05.001openalex-snapshot
Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.1016/j.hemonc.2019.10.001openalex-snapshot
Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation
inferred← citeshttps://doi.org/10.1016/j.hemonc.2021.05.001openalex-snapshot
Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1016/j.humimm.2018.06.006openalex-snapshot
Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients
inferred← citeshttps://doi.org/10.1016/j.humimm.2026.111721openalex-snapshot
Pre-existing influenza antibodies, younger age, and increased CD4 TE+EM predict influenza vaccination responses in transplant recipients
inferred← citeshttps://doi.org/10.1016/j.humimm.2026.112064openalex-snapshot
Graft CD3+/CD4 − CD8− T-cell ratio: a predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients
inferred← citeshttps://doi.org/10.1016/j.idc.2019.02.002openalex-snapshot
Antimicrobial Prophylaxis and Preemptive Approaches for the Prevention of Infections in the Stem Cell Transplant Recipient, with Analogies to the Hematologic Malignancy Patient
showing the first 200 of 952 · page through all 952
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.